These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 22217270

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells.
    Gavelová M, Hladíková J, Vildová L, Novotná R, Vondrácek J, Krcmár P, Machala M, Skálová L.
    Chem Biol Interact; 2008 Oct 22; 176(1):9-18. PubMed ID: 18755171
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
    Kassner N, Huse K, Martin HJ, Gödtel-Armbrust U, Metzger A, Meineke I, Brockmöller J, Klein K, Zanger UM, Maser E, Wojnowski L.
    Drug Metab Dispos; 2008 Oct 22; 36(10):2113-20. PubMed ID: 18635746
    [Abstract] [Full Text] [Related]

  • 7. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 22; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases.
    Hofman J, Skarka A, Havrankova J, Wsol V.
    Biochem Pharmacol; 2015 Aug 01; 96(3):168-78. PubMed ID: 25986883
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiproliferative activity of pomiferin in normal (MCF-10A) and transformed (MCF-7) breast epithelial cells.
    Yang R, Hanwell H, Zhang J, Tsao R, Meckling KA.
    J Agric Food Chem; 2011 Dec 28; 59(24):13328-36. PubMed ID: 22087557
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line.
    Rusetskaya NV, Khariton N, Yurchenko OV, Chekhun VF.
    Exp Oncol; 2011 Jun 28; 33(2):78-82. PubMed ID: 21716203
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro.
    Rudolfová P, Hanušová V, Skálová L, Bártíková H, Matoušková P, Boušová I.
    Acta Pharm; 2014 Jun 28; 64(2):199-209. PubMed ID: 24914720
    [Abstract] [Full Text] [Related]

  • 18. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
    Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, Escalon E, Melnick SJ.
    Anticancer Res; 2005 Jun 28; 25(5):3293-302. PubMed ID: 16101141
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.